429 related articles for article (PubMed ID: 15852596)
21. Drug card setback highlights need for cost relief.
Gundling RL
Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
[TBL] [Abstract][Full Text] [Related]
22. Improving the design of competitive bidding in Medicare Advantage.
Cawley JH; Whitford AB
J Health Polit Policy Law; 2007 Apr; 32(2):317-47. PubMed ID: 17463410
[TBL] [Abstract][Full Text] [Related]
23. Congress passes landmark Medicare prescription drug bill to benefit America's seniors and the physicians who care for them.
Zeno L
J Ark Med Soc; 2004 Feb; 100(8):254. PubMed ID: 14999883
[No Abstract] [Full Text] [Related]
24. The new Medicare prescription-drug legislation.
Altman DE
N Engl J Med; 2004 Jan; 350(1):9-10. PubMed ID: 14702422
[No Abstract] [Full Text] [Related]
25. Medicare program: Medicare Advantage and prescription drug programs MIPPA drug formulary & protected classes policies. Interim final rule with comment period.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2009 Jan; 74(11):2881-8. PubMed ID: 19385109
[TBL] [Abstract][Full Text] [Related]
26. Medicare program; catastrophic outpatient drug benefit--HCFA. Proposed rule.
Fed Regist; 1989 Sep; 54(172):37190-208. PubMed ID: 10303826
[TBL] [Abstract][Full Text] [Related]
27. Access to Medicare Part D gap coverage more scarce in 2007.
Consult Pharm; 2007 Jan; 22(1):60-1. PubMed ID: 17380599
[No Abstract] [Full Text] [Related]
28. Coverage and use of prescription drugs in nursing homes: implications for the medicare modernization act.
Stuart B; Simoni-Wastila L; Baysac F; Shaffer T; Shea D
Med Care; 2006 Mar; 44(3):243-9. PubMed ID: 16501395
[TBL] [Abstract][Full Text] [Related]
29. Molecular medicine, the Medicare drug benefit, and the need for cost control.
Gillick MR
J Am Geriatr Soc; 2006 Sep; 54(9):1442-6. PubMed ID: 16970656
[TBL] [Abstract][Full Text] [Related]
30. Pharmacy utilization and the Medicare Modernization Act.
Maio V; Pizzi L; Roumm AR; Clarke J; Goldfarb NI; Nash DB; Chess D
Milbank Q; 2005; 83(1):101-30. PubMed ID: 15787955
[TBL] [Abstract][Full Text] [Related]
31. Lessons for Medicare Part D in the hemodialysis community.
Nayeem AI; Chertow GM
BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
[TBL] [Abstract][Full Text] [Related]
32. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
Patel UD; Davis MM
J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
[TBL] [Abstract][Full Text] [Related]
33. Impact of the Medicare prescription drug benefit on home- and community-based services waiver programs.
Milligan CJ
Issue Brief (Commonw Fund); 2005 Apr; (815):1-8. PubMed ID: 15856612
[TBL] [Abstract][Full Text] [Related]
34. Medicare prescription drug/reform act: medicine chest or Pandora's box?
Hager MH
J Am Diet Assoc; 2004 Jun; 104(6):890-1. PubMed ID: 15175585
[No Abstract] [Full Text] [Related]
35. Medicare and the politics of prescription drug pricing.
Oberlander J
N C Med J; 2003; 64(6):303-4. PubMed ID: 14983626
[No Abstract] [Full Text] [Related]
36. The implications of a Medicare prescription drug benefit.
Manag Care Interface; 2000 May; 13(5):44-5. PubMed ID: 11067393
[No Abstract] [Full Text] [Related]
37. United States pharmacopeia development of the Medicare model formulary guidelines.
Bielory L;
Am J Geriatr Cardiol; 2005; 14(6):301-7. PubMed ID: 16276127
[TBL] [Abstract][Full Text] [Related]
38. Medicare drugs.
Poisal JA
Health Care Financ Rev; 2003; 25(2):1-5. PubMed ID: 15124373
[TBL] [Abstract][Full Text] [Related]
39. The last prescription drug benefit: the Medicare Catastrophic Coverage Act of 1988.
Pentecost MJ
J Am Coll Radiol; 2006 Apr; 3(4):240-2. PubMed ID: 17412053
[No Abstract] [Full Text] [Related]
40. Are women better off because of the new Medicare drug legislation?
Moon M
Womens Health Issues; 2005; 15(1):1-4. PubMed ID: 15661581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
